SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-000442
Filing Date
2021-01-04
Accepted
2021-01-04 17:48:25
Documents
2
Period of Report
2021-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5244
2 POA DOCUMENT poa.txt EX-24.3_952872 3218
  Complete submission text file 0001209191-21-000442.txt   9810
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Issuer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4520 EAST WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814
Business Address
Donley Matthew Maxwell (Reporting) CIK: 0001636642 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36421 | Film No.: 21503035